Abstract
Systemic sclerosis (SSc), an autoimmune disease of connective tissue, is characterized by inflammation, fibrosis, and vessel endothelial damage. Products of Integrin subunit beta 2 (ITGB2) and selectin L (SELL) genes participate in several functional pathways of immune system. The aim of this investigation was to survey the transcript level of ITGB2 and SELL genes as well as methylation status of CpG sites in promoter region of differently expressed gene in PBMCs of SSc patients. PBMCs were isolated from whole blood of 50 SSc patients and 30 healthy controls. Total RNA and DNA contents of PBMCs were extracted. Gene expression was analyzed by real-time PCR using the SYBR Green PCR Master Mix. To investigate the methylation status of CpG sites, DNA samples were treated by bisulfite, amplified through nested PCR, and sequenced through Sanger difficult sequencing method. ITGB2 gene in PBMCs of SSc patients was overexpressed significantly in comparison to healthy controls. However, no altered SELL expression was observed. Three CpG sites of 12, 13 and 14 were significantly hypomethylated in patients group, despite overall methylation status of ITGB2 gene promoter revealed no significant difference between study groups. There was no statistically significant correlation between methylation status of ITGB2 promoter and the gene expression in patients. Regarding to lack of correlation of increased expression of ITGB2 with its promoter hypomethylation in SSc patients, our study suggests that upregulation of ITGB2 in PBMCs from SSc patients is probably due to another mechanism other than methylation alteration.
Similar content being viewed by others
References
Perosa F, Prete M, Di Lernia G, Ostuni C, Favoino E, Valentini G (2016) Anti-centromere protein A antibodies in systemic sclerosis: significance and origin. Autoimmun Rev 15:102–109. https://doi.org/10.1016/j.autrev.2015.10.001
Denton C (2015) Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol 33:S3-S7
Hutterer E, Asslaber D, Caldana C, Krenn PW, Zucchetto A, Gattei V, Greil R, Hartmann TN (2015) CD18 (ITGB2) expression in chronic lymphocytic leukaemia is regulated by DNA methylation-dependent and-independent mechanisms. Br J Haematol 169:286–289. https://doi.org/10.1111/bjh.13188
Shimada Y, Hasegawa M, Takehara K, Sato S (2001) Elevated serum l-selectin levels and decreased l-selectin expression on CD8+ lymphocytes in systemic sclerosis. Clin Exp Immunol 124:474–479. https://doi.org/10.1046/j.1365-2249.2001.01514.x
Miao C-g, Xiong Y-y, Yu H, Zhang X-l, Qin M-s, Song T-w, Du C-l (2015) Critical roles of microRNAs in the pathogenesis of systemic sclerosis: new advances, challenges and potential directions. Int Immunopharmacol 28:626–633. https://doi.org/10.1016/j.intimp.2015.07.042
Karimizadeh E, Gharibdoost F, Motamed N, Jafarinejad-Farsangi S, Jamshidi A, Mahmoudi M (2015) c-Abl silencing reduced the inhibitory effects of TGF-β1 on apoptosis in systemic sclerosis dermal fibroblasts. Mol Cell Biochem 405:169–176. https://doi.org/10.1007/s11010-015-2408-0
Karimizadeh E, Motamed N, Mahmoudi M, Jafarinejad-Farsangi S, Jamshidi A, Faridani H, Gharibdoost F (2015) Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts. Arch Dermatol Res 307:135–142. https://doi.org/10.1007/s00403-014-1532-0
Jafarinejad-Farsangi S, Farazmand A, Gharibdoost F, Karimizadeh E, Noorbakhsh F, Faridani H, Mahmoudi M, Jamshidi AR (2016) Inhibition of MicroRNA-21 induces apoptosis in dermal fibroblasts of patients with systemic sclerosis. Int J Dermatol 55:1259–1267. https://doi.org/10.1111/ijd.13308
Yousefi B, Mahmoudi M, Sarafnejad A, Karimizadeh E, Farhadi E, Jamshidi AR, Kavosi H, Aslani S, Gharibdoost F (2017) Downregulation of Aquaporin3 in systemic sclerosis dermal fibroblasts. Iran J Allergy Asthma Immunol 16:228
Almasi S, Aslani S, Poormoghim H, Jamshidi A, Poursani S, Mahmoudi M (2016) Gene expression profiling of toll-like receptor 4 and 5 in peripheral blood mononuclear cells in rheumatic disorders: ankylosing spondylitis and rheumatoid arthritis. Iran J Allergy Asthma Immunol 15:87
Jafarinejad-Farsangi S, Farazmand A, Mahmoudi M, Gharibdoost F, Karimizadeh E, Noorbakhsh F, Faridani H, Jamshidi AR (2015) MicroRNA-29a induces apoptosis via increasing the Bax: Bcl-2 ratio in dermal fibroblasts of patients with systemic sclerosis. Autoimmunity 48:369–378. https://doi.org/10.3109/08916934.2015.1030616
Ferri C, Sebastiani M, Monaco AL, Iudici M, Giuggioli D, Furini F, Manfredi A, Cuomo G, Spinella A, Colaci M (2014) Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients’ population and review of the literature. Autoimmun Rev 13:1026–1034. https://doi.org/10.1016/j.autrev.2014.08.029
Li Y, Huang J, Guo M, Zuo X (2015) MicroRNAs regulating signaling pathways: potential biomarkers in systemic sclerosis. Genom Proteom Bioinform 13:234–241. https://doi.org/10.1016/j.gpb.2015.07.001
Mahmoudi M, Fallahian F, Sobhani S, Ghoroghi S, Jamshidi A, Poursani S, Dolati M, Hosseinpour Z, Gharibdoost F (2017) Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis. Clin Rheumatol 36:853–862. https://doi.org/10.1007/s10067-016-3526-0
Abtahi S, Farazmand A, Mahmoudi M, Ashraf-Ganjouei A, Javinani A, Nazari B, Kavosi H, Amirzargar A, Jamshidi A, Gharibdoost F (2015) IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis. Int J Immunogenet 42:423–427. https://doi.org/10.1111/iji.12212
Luo Y, Wang Y, Shu Y, Lu Q, Xiao R (2015) Epigenetic mechanisms: an emerging role in pathogenesis and its therapeutic potential in systemic sclerosis. Int J Biochem Cell Biol 67:92–100. https://doi.org/10.1016/j.biocel.2015.05.023
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484–492. https://doi.org/10.1038/nrg3230
Quintero-Ronderos P, Montoya-Ortiz G (2012) Epigenetics and autoimmune diseases. Autoimmun Dis. https://doi.org/10.1155/2012/593720
Estécio MR, Issa J-PJ (2011) Dissecting DNA hypermethylation in cancer. FEBS Lett 585:2078–2086. https://doi.org/10.1016/j.febslet.2010.12.001
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324:930–935. https://doi.org/10.1126/science.1170116
Tan F, Zhou X, Mayes M, Gourh P, Guo X, Marcum C, Jin L, Arnett F (2006) Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology 45:694–702. https://doi.org/10.1093/rheumatology/kei244
Yassaee VR, Hashemi-Gorji F, Boosaliki S, Parvaneh N (2016) Mutation spectra of the ITGB2 gene in Iranian families with leukocyte adhesion deficiency type 1. Hum Immunol 77:191–195. https://doi.org/10.1016/j.humimm.2015.11.019
Nasiri Kalmarzi M (2015) Investigation of ITGB2 gene in 12 new cases of leukocyte adhesion deficiency-type I Revealed four novel mutations from Iran. Arch Iran Med 18:760
Stavarachi M, Apostol P, CIMPONERIU D, Toma M, Butoianu N, and GAVRILĂ L (2009) Possible association between l-selectin gene P213S polymorphism and respiratory complications of childhood spinal muscular atrophy patients. Rom Biotechnol Lett 14:4119–4122
Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA, Carreira PE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747. https://doi.org/10.1002/art.38098
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nat protoc 3:1101. https://doi.org/10.1038/nprot.2008.73
Sambrook J, Russell DW (2006) Purification of nucleic acids by extraction with phenol: chloroform. Cold Spring Harb Protoc 2006:pdb. https://doi.org/10.1101/pdb.prot4455
Patterson K, Molloy L, Qu W, Clark S (2011) DNA methylation: bisulphite modification and analysis. J Vis Exp. https://doi.org/10.3791/3170
Aslani S, Mahmoudi M, Garshasbi M, Jamshidi AR, Karami J, Nicknam MH (2016) Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol 35:2723–2731. https://doi.org/10.1007/s10067-016-3403-x
Karami J, Mahmoudi M, Amirzargar A, Gharshasbi M, Jamshidi A, Aslani S, Nicknam M (2017) Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun 18:170–175. https://doi.org/10.1038/gene.2017.17
Rezaei R, Mahmoudi M, Gharibdoost F, Kavosi H, Dashti N, Imeni V, Jamshidi A, Aslani S, Mostafaei S, Vodjgani M (2017) IRF7 gene expression profile and methylation of its promoter region in patients with systemic sclerosis. Int J Rheum Dis 20:1551–1561. https://doi.org/10.1111/1756-185X.13175
Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Gen 7:21–33. https://doi.org/10.1038/nrg1748
Aslani S, Mahmoudi M, Karami J, Jamshidi AR, Malekshahi Z, Nicknam MH (2016) Epigenetic alterations underlying autoimmune diseases. Autoimmunity 49:69–83. https://doi.org/10.3109/08916934.2015.1134511
Aslani S, Jafari N, Javan MR, Karami J, Ahmadi M, Jafarnejad M (2017) Epigenetic modifications and therapy in multiple sclerosis. NeuroMol Med 19:11–23. https://doi.org/10.1007/s12017-016-8422-x
Mahmoudi M, Aslani S, Nicknam MH, Karami J, Jamshidi AR (2017) New insights toward the pathogenesis of ankylosing spondylitis; genetic variations and epigenetic modifications. Mod Rheumatol 27:198–209. https://doi.org/10.1080/14397595.2016.1206174
Ahmadi M, Gharibi T, Dolati S, Rostamzadeh D, Aslani S, Baradaran B, Younesi V, Yousefi M (2017) Epigenetic modifications and epigenetic based medication implementations of autoimmune diseases. Biomed Pharmacother 87:596–608. https://doi.org/10.1016/j.biopha.2016.12.072
Foma AM, Aslani S, Karami J, Jamshidi A, Mahmoudi M (2017) Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous. Inflamm Res. https://doi.org/10.1007/s00011-017-1082-y
Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 117:557–567. https://doi.org/10.1172/JCI31139
Altorok N, Almeshal N, Wang Y, Kahaleh B (2014) Epigenetics, the holy grail in the pathogenesis of systemic sclerosis. Rheumatology 54:1759–1770. https://doi.org/10.1093/rheumatology/keu155
Altorok N, Tsou P-S, Coit P, Khanna D, Sawalha AH (2014) Genome-wide DNA methylation analysis in dermal fibroblasts from patients with diffuse and limited systemic sclerosis reveals common and subset-specific DNA methylation aberrancies. Ann Rheum Dis 74:1612–1620. https://doi.org/10.1136/annrheumdis-2014-205303
Tan F, Zhou X, Mayes M, Gourh P, Guo X, Marcum C, Jin L, Arnett F Jr. (2006) Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology 45:694–702. https://doi.org/10.1093/rheumatology/kei244
Jones PA (2012) Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 13:484. https://doi.org/10.1038/nrg3230
Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood JS (2008) Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 39:610–618. https://doi.org/10.1165/rcmb.2007-0322OC
Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18:1028–1040. https://doi.org/10.1038/nm.2807
Bird AP, Wolffe AP (1999) Methylation-induced repression—belts, braces, and chromatin. Cell 99:451–454. https://doi.org/10.1016/S0092-8674(00)81532-9
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403:41–45. https://doi.org/10.1038/47412
Stancheva I (2005) Caught in conspiracy: cooperation between DNA methylation and histone H3K9 methylation in the establishment and maintenance of heterochromatin. Biochem Cell Biol 83:385–395. https://doi.org/10.1139/o05-043
Mizuno S-i, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H (2001) Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 97:1172–1179. https://doi.org/10.1182/blood.V97.5.1172
Fujita N, Takebayashi S-i, Okumura K, Kudo S, Chiba T, Saya H, Nakao M (1999) Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms. Mol Cell Biol 19:6415–6426. https://doi.org/10.1128/MCB.19.9.6415
Gregory RI, Randall TE, Johnson CA, Khosla S, Hatada I, O’Neill LP, Turner BM, Feil R (2001) DNA methylation is linked to deacetylation of histone H3, but not H4, on the imprinted genes Snrpnand U2af1-rs1. Mol Cell Biol 21:5426–5436. https://doi.org/10.1128/MCB.21.16.5426-5436.2001
Lunyak VV, Burgess R, Prefontaine GG, Nelson C, Sze S-H, Chenoweth J, Schwartz P, Pevzner PA, Glass C, Mandel G (2002) Corepressor-dependent silencing of chromosomal regions encoding neuronal genes. Science 298:1747–1752. https://doi.org/10.1126/science.1076469
Lande-Diner L, Zhang J, Ben-Porath I, Amariglio N, Keshet I, Hecht M, Azuara V, Fisher AG, Rechavi G, Cedar H (2007) Role of DNA methylation in stable gene repression. J Biol Chem 282:12194–12200. https://doi.org/10.1074/jbc.M607838200
Lawson BR, Eleftheriadis T, Tardif V, Gonzalez-Quintial R, Baccala R, Kono DH, Theofilopoulos AN (2012) Transmethylation in immunity and autoimmunity. Clin Immunol 143:8–21. https://doi.org/10.1016/j.clim.2011.10.007
Acknowledgements
Authors are deeply grateful of the individuals who contributed to the accomplishment of this study.
Funding
This study was funded by the Deputy of Research, Tehran University of Medical Sciences (Grant no. 95-01-30-31356).
Author information
Authors and Affiliations
Contributions
ND: email: naviddashtigoolahgoolah@yahoo.com. Performed the experiments and participated in manuscript drafting. MM: email: mahmoudim@tums.ac.ir. Developed the main idea and red the manuscript critically. FG: email: gharibdoost@sina.tums.ac.ir. Provided the financial support of the project. HK: email: h-kavosi@sina.tums.ac.ir. Examined the SSc patients. RR: email: ramin.rezaei25@gmail.com. Participated in performing the experiments. VI: email: vahide.amini@yahoo.com. Participated in questionnaire filling of the patients and conducting experiments. AJ: email: jamshidia@tums.ac.ir. Provided the financial support of the project. SA: email: s-aslani@razi.tums.ac.ir. Participated in manuscript writing. SM: email: mostafa.shayan@modares.ac.ir. Performed the statistical analysis. MV: email: vojganim@sina.tums.ac.ir. Provided the financial support of the project.
Corresponding authors
Ethics declarations
Ethical approval
All participants in the study were treated in agreement with the ethical standards of the Ethics Committee at Tehran University of Medical Sciences and with the revised Helsinki Declaration in 2000.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
296_2017_3915_MOESM1_ESM.tif
Correlation of mRNA expression level of ITGB2 with methylation percentage in (A) SSc patients, (B) dSSc patients, and (C) lSSc patients (rho; Spearman’s correlation coefficient) (TIF 51 KB)
296_2017_3915_MOESM2_ESM.tif
Scatter plots demonstrating the correlation of Rodnan scores with mRNA expression of ITGB2 (A) and methylation level of ITGB2 promoter in SSc patients. Rodnan score correlation with mRNA expression and promoter methylation of ITGB2 in dSSc patients is shown in plots C and D, respectively. Rodnan score correlation with mRNA expression and promoter methylation of ITGB2 in lSSc patients is shown in plots E and F, respectively (r; Pearson’s correlation coefficient) (TIF 186 KB)
Rights and permissions
About this article
Cite this article
Dashti, N., Mahmoudi, M., Gharibdoost, F. et al. Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis. Rheumatol Int 38, 489–498 (2018). https://doi.org/10.1007/s00296-017-3915-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-017-3915-y